Annual accounts receivable:
$36.54M+$12.46M(+51.70%)Summary
- As of today (May 23, 2025), AUPH annual accounts receivable is $36.54 million, with the most recent change of +$12.46 million (+51.70%) on December 31, 2024.
- During the last 3 years, AUPH annual accounts receivable has risen by +$21.13 million (+137.08%).
- AUPH annual accounts receivable is now at all-time high.
Performance
AUPH Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$40.35M+$3.81M(+10.41%)Summary
- As of today (May 23, 2025), AUPH quarterly accounts receivable is $40.35 million, with the most recent change of +$3.81 million (+10.41%) on March 31, 2025.
- Over the past year, AUPH quarterly accounts receivable has increased by +$11.44 million (+39.58%).
- AUPH quarterly accounts receivable is now -3.40% below its all-time high of $41.77 million, reached on September 30, 2022.
Performance
AUPH Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AUPH Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.7% | +39.6% |
| 3 y3 years | +137.1% | +97.8% |
| 5 y5 years | - | - |
AUPH Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.0% | -3.4% | +199.3% |
| 5 y | 5-year | at high | >+9999.0% | -3.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -3.4% | >+9999.0% |
AUPH Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $40.35M(+10.4%) |
| Dec 2024 | $36.54M(+51.7%) | $36.54M(+0.2%) |
| Sep 2024 | - | $36.48M(+42.9%) |
| Jun 2024 | - | $25.52M(-11.7%) |
| Mar 2024 | - | $28.91M(+20.0%) |
| Dec 2023 | $24.09M(+78.7%) | $24.09M(-36.5%) |
| Sep 2023 | - | $37.95M(+94.6%) |
| Jun 2023 | - | $19.50M(+2.4%) |
| Mar 2023 | - | $19.05M(+41.3%) |
| Dec 2022 | $13.48M(-12.5%) | $13.48M(-67.7%) |
| Sep 2022 | - | $41.77M(+129.9%) |
| Jun 2022 | - | $18.17M(-10.9%) |
| Mar 2022 | - | $20.40M(+32.4%) |
| Dec 2021 | $15.41M(>+9900.0%) | $15.41M(+57.1%) |
| Sep 2021 | - | $9.81M(+122.1%) |
| Jun 2021 | - | $4.42M(+272.2%) |
| Mar 2021 | - | $1.19M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $470.00K(+89.5%) |
| Jun 2019 | - | $248.00K(-34.0%) |
| Mar 2019 | - | $376.00K(+73.3%) |
| Dec 2018 | $217.00K(+99.1%) | $217.00K(-71.4%) |
| Sep 2018 | - | $759.00K(+147.2%) |
| Jun 2018 | - | $307.00K(+36.4%) |
| Mar 2018 | - | $225.00K(+106.4%) |
| Dec 2017 | $109.00K(+26.7%) | $109.00K(-11.4%) |
| Mar 2017 | - | $123.00K(+43.0%) |
| Dec 2016 | $86.00K(+83.0%) | $86.00K(-12.2%) |
| Sep 2016 | - | $98.00K(+100.0%) |
| Jun 2016 | - | $49.00K(+4.3%) |
| Mar 2016 | - | $47.00K(0.0%) |
| Dec 2015 | $47.00K(-48.9%) | $47.00K(-14.5%) |
| Sep 2015 | - | $55.00K(-35.3%) |
| Jun 2015 | - | $85.00K(-25.4%) |
| Mar 2015 | - | $114.00K(+23.9%) |
| Dec 2014 | $92.00K(-13.2%) | $92.00K(+84.0%) |
| Sep 2014 | - | $50.00K(-56.1%) |
| Jun 2014 | - | $114.00K(+14.0%) |
| Mar 2014 | - | $100.00K(-5.7%) |
| Dec 2013 | $106.00K(-42.4%) | $106.00K(+35.0%) |
| Sep 2013 | - | $78.50K(-56.1%) |
| Jun 2013 | - | $178.70K(-2.8%) |
| Mar 2013 | - | $183.80K(-0.1%) |
| Dec 2012 | $184.00K(+308.0%) | $184.00K(-13.3%) |
| Sep 2012 | - | $212.30K(-41.6%) |
| Jun 2012 | - | $363.80K(-62.6%) |
| Mar 2012 | - | $973.20K(+2057.9%) |
| Dec 2011 | $45.10K | $45.10K(-79.5%) |
| Sep 2011 | - | $219.70K(-1.5%) |
| Jun 2011 | - | $223.00K(-2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2011 | - | $228.40K(+100.4%) |
| Dec 2010 | $114.00K(-77.0%) | $114.00K(+13.1%) |
| Sep 2010 | - | $100.80K(-13.6%) |
| Jun 2010 | - | $116.70K(-55.8%) |
| Mar 2010 | - | $263.90K(-46.8%) |
| Dec 2009 | $495.70K(+21.9%) | $495.70K(-3.0%) |
| Sep 2009 | - | $510.80K(+390.2%) |
| Jun 2009 | - | $104.20K(-58.4%) |
| Mar 2009 | - | $250.30K(-38.5%) |
| Dec 2008 | $406.70K(-16.8%) | $406.70K(+49.5%) |
| Sep 2008 | - | $272.10K(-31.6%) |
| Jun 2008 | - | $397.90K(-14.9%) |
| Mar 2008 | - | $467.30K(-4.4%) |
| Dec 2007 | $488.70K(+23.0%) | $488.70K(+64.5%) |
| Sep 2007 | - | $297.10K(-16.8%) |
| Jun 2007 | - | $357.00K(-27.4%) |
| Mar 2007 | - | $491.50K(+23.7%) |
| Dec 2006 | $397.20K(+3.2%) | $397.20K(+19.9%) |
| Sep 2006 | - | $331.40K(-3.1%) |
| Jun 2006 | - | $341.90K(-5.6%) |
| Mar 2006 | - | $362.00K(-5.9%) |
| Dec 2005 | $384.90K(+11.0%) | $384.90K(-2.3%) |
| Sep 2005 | - | $393.90K(+30.4%) |
| Jun 2005 | - | $302.00K(-10.9%) |
| Mar 2005 | - | $338.90K(-2.3%) |
| Dec 2004 | $346.90K(+20.3%) | $346.90K(-9.6%) |
| Sep 2004 | - | $383.80K(+82.1%) |
| Jun 2004 | - | $210.80K(-23.4%) |
| Mar 2004 | - | $275.30K(-4.5%) |
| Dec 2003 | $288.40K(-87.1%) | $288.40K(+21.8%) |
| Sep 2003 | - | $236.70K(-36.1%) |
| Jun 2003 | - | $370.50K(-74.2%) |
| Mar 2003 | - | $1.44M(-35.5%) |
| Dec 2002 | $2.23M(+476.6%) | $2.23M(+18.6%) |
| Sep 2002 | - | $1.88M(-57.6%) |
| Jun 2002 | - | $4.43M(+1006.5%) |
| Mar 2002 | - | $400.70K(+44.1%) |
| Dec 2001 | $386.90K(+150.6%) | - |
| Aug 2001 | - | $278.10K(-23.4%) |
| May 2001 | - | $362.90K(-26.2%) |
| Feb 2001 | - | $492.00K(+218.7%) |
| Nov 2000 | $154.40K(+13.7%) | $154.40K(+9.3%) |
| Aug 2000 | - | $141.20K(-29.5%) |
| May 2000 | - | $200.20K(-27.4%) |
| Feb 2000 | - | $275.70K(+103.0%) |
| Nov 1999 | $135.80K(-30.5%) | $135.80K(-59.4%) |
| Aug 1999 | - | $334.50K(+64.4%) |
| May 1999 | - | $203.50K(-23.3%) |
| Feb 1999 | - | $265.20K |
| Nov 1998 | $195.30K | - |
FAQ
- What is Aurinia Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual accounts receivable year-on-year change?
- What is Aurinia Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Aurinia Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AUPH is $36.54M
What is the all time high annual accounts receivable for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual accounts receivable is $36.54M
What is Aurinia Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AUPH annual accounts receivable has changed by +$12.46M (+51.70%)
What is Aurinia Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AUPH is $40.35M
What is the all time high quarterly accounts receivable for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly accounts receivable is $41.77M
What is Aurinia Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AUPH quarterly accounts receivable has changed by +$11.44M (+39.58%)